Session Details

Important aspects of percutaneous valve therapy
29 Aug 15:30 - 16:30 Aortic valve disease Moderated Posters Moderated Posters - Zone A
Chairpersons: Vasco GAMA RIBEIRO (Vila Nova De Gaia, PT), Christoph NABER (Essen, DE)

Abstract Access slides, videos, reports online via ESC Congress 365 Other resources

Presentations list

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
15:30P1081Early benefits of transcatheter aortic valve replacement on the severity of secondary mitral regurgitationClaudiu Ionut STOICESCU (Bucharest, RO)
15:35P1082Effectiveness and durability at two years with CoreValve transcatheter aortic valveGerhard SCHULER (Leipzig, DE)
15:40P1083In-hospital outcome of aortic regurgitation after transcatheter aortic valve implantation: results from the prospective multicentre german TAVI registryMohamed ABDEL-WAHAB (Bad Segeberg, DE)
15:45P1084Hemodynamic and clinical impact of percutaneous mitral repair using the mitral clip systemJoerg HAUSLEITER (Muenchen, DE)
15:50P1085Transapical aortic valve implantation after previous heart surgeryThorsten DREWS (Berlin, DE)
15:55P1086Safety and efficacy comparison between implanted and non-implanted patients in the TITAN trial using the CARILLON Mitral Contour System to treat functional mitral regurgitationUta C HOPPE (Salzburg, AT)
16:00P1087Failing aortic valve prosthesis treated by percutaneously implanted CoreValve prosthesisFelix WOITEK (Leipzig, DE)
16:05P1088Is redo Percutaneous Mitral balloon Valvuloplasty (PMV) indicated in patients with post-PMV mitral restenosis?Bassem JERBI (Sfax, TN)
16:10 Discussion.To Be Announced

Who we are

What we do

How we work

More ESC